COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment-A Retrospective Study.
Ali NuhNewara RamadanLisa NwankwoJackie DonovanBrijesh PatelAnand ShahSujal R DesaiDarius Armstrong-JamesPublished in: Journal of fungi (Basel, Switzerland) (2023)
In COVID-19 ECMO patients, pulmonary aspergillosis incidence was 10% and associated with very high mortality. Our results support the role of BALF in the diagnosis of pulmonary aspergillosis in COVID-19 ECMO patients. However, the diagnostic utility of BDG, serum GM, and CT scans is unclear.